MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
128.28%
Quick Ratio
110.93%
Cash Ratio
28.91%
Debt to Asset Ratio
158.46%
Unit: Dollar
Assets Breakdown
    • Accounts receivable, net
    • Less accumulated depreciation
    • Cash
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Notes payable-Nonrelated Party
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash
449,325
263,827
548,946
514,797
Accounts receivable, net
1,167,571
873,669
561,667
652,252
Inventory, net
269,518
248,537
213,761
201,627
Prepaid expenses and other current assets
107,021
134,208
55,509
93,977
Total current assets
1,993,435
1,520,241
1,379,883
1,462,653
Property, plant, and equipment, gross
1,138,493
885,466
884,619
841,414
Less accumulated depreciation
566,758
540,560
518,304
494,392
Property and equipment, net
571,735
344,906
366,315
347,022
Operating lease right of use assets
61,120
80,522
99,464
117,962
Total assets
2,626,290
1,945,669
1,845,662
1,927,637
Accounts payable
563,100
385,235
436,083
491,659
Accrued expenses
619,046
593,289
493,792
390,892
Deferred revenue
311,765
311,765
300,000
300,000
Current portion of operating lease liabilities
60,090
78,949
76,410
73,935
Total current liabilities
1,554,001
1,369,238
1,306,285
1,256,486
Deferred revenue long term
857,353
935,294
975,000
1,050,000
Notes payable-Nonrelated Party
1,436,250
820,000
300,000
-
Notes payable-Related Party
314,000
205,000
200,000
-
Non-current portion of operating lease liabilities
0
0
20,936
40,757
Total liabilities
4,161,604
3,329,532
2,802,221
2,347,243
Common stock 0.0001 par value, 100,000,000 shares authorized, 48,418,524 and 48,179,039 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
4,842
4,829
4,818
4,788
Additional paid-in capital
34,128,073
34,001,936
33,810,785
33,769,288
Accumulated deficit
-35,668,229
-35,390,628
-34,772,162
-34,193,682
Total stockholders' deficit
-1,535,314
-1,383,863
-956,559
-419,606
Total liabilities and stockholders' deficit
2,626,290
1,945,669
1,845,662
1,927,637
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Accounts receivable, net$1,167,571 (264.36%↑ Y/Y)Cash$449,325 (42.03%↑ Y/Y)Inventory, net$269,518 (62.54%↑ Y/Y)Prepaid expenses andother current assets$107,021 (111.21%↑ Y/Y)Property, plant, andequipment, gross$1,138,493 (35.31%↑ Y/Y)Total current assets$1,993,435 (133.62%↑ Y/Y)Property and equipment,net$571,735 (54.45%↑ Y/Y)Operating lease right ofuse assets$61,120 (-55.07%↓ Y/Y)Less accumulateddepreciation$566,758 (20.27%↑ Y/Y)Total assets$2,626,290 (93.18%↑ Y/Y)Accumulated deficit-$35,668,229 (-5.98%↓ Y/Y)Total liabilities andstockholders' deficit$2,626,290 (93.18%↑ Y/Y)Total stockholders'deficit-$1,535,314 (-86.20%↓ Y/Y)Additional paid-in capital$34,128,073 (3.96%↑ Y/Y)Common stock 0.0001 parvalue, 100,000,000...$4,842 (3.40%↑ Y/Y)Total liabilities$4,161,604 (90.55%↑ Y/Y)Total currentliabilities$1,554,001 (55.56%↑ Y/Y)Notespayable-Nonrelated Party$1,436,250 Deferred revenue longterm$857,353 (-23.79%↓ Y/Y)Notespayable-Related Party$314,000 Accrued expenses$619,046 (96.80%↑ Y/Y)Accounts payable$563,100 (79.97%↑ Y/Y)Deferred revenue$311,765 (3.92%↑ Y/Y)Current portion ofoperating lease...$60,090 (-15.98%↓ Y/Y)

Nuo Therapeutics, Inc. (AURX)

Nuo Therapeutics, Inc. (AURX)